Skip to main content
EN
Menu

Why Intuitive Surgical stock moves

Intuitive Surgical fell sharply.

Written after the close on ·

Why today

16,413 news analyzed today

Intuitive Surgical fell sharply.

The shares moved against the market, and the Healthcare sector was roughly flat.

No single company event clearly explains the drop; several same-day write-ups noted the decline without naming a cause.

Over the last five trading days the stock rose clearly, but the S&P 500 fell sharply over the same days, so the shares moved against the broad market.

Earlier this week, analysts raised their earnings estimates, which likely supported the stock's rebound.

Today's move of −3.36% was 2.6 times a normal day's 1.3%. S&P 500 moved +0.31% on the same day.

Intuitive Surgical −3.36%S&P 500 +0.31%Against the market

Earlier days →

See the chart in ChartCompass, with every move explained →

What analysts expect, and how often they have been right

Analysts’ estimates for Intuitive Surgical.

Intuitive Surgical earned more than expected in 8 out of 8 reports.

For comparison, about 82% of reports from US companies beat the estimate in the last three years.

The share moved in the same direction as the earnings surprise in 3 out of 8 reports with a measured move, against about 55% of reports from US companies.

Ratings

Now
Buy 26Hold 6Sell 2
3 months ago
Buy 24Hold 8Sell 1

A rating is the analyst’s own opinion about the share. On US shares since 2013, the price a year later was higher about as often when most analysts said buy as when few did.

Price targets

Latest price $452.80

Price targets
Low 324Average 486High 685

The average target is $485.57, +7% relative to the latest price of $452.80. The range is $324.00–$685.00. A target is the analyst’s estimate of a future share price. 30 analysts gave a target. On US shares, a year after earlier targets this far above the price were set, the price stood at or above about 6 in 10 of them.

Earnings against expectations, and the share’s reaction

Earnings against expectations, and the share’s reaction1.52.02.42.83.22025-01-23: 2.21; Expected EPS: 1.7923/1’25−4.0%2025-04-22: 1.81; Expected EPS: 1.7322/4’25+1.9%2025-07-22: 2.19; Expected EPS: 1.9222/7’25−1.8%2025-10-21: 2.40; Expected EPS: 1.9921/10’25+13.9%2026-01-22: 2.53; Expected EPS: 2.2722/1’26−0.3%2026-04-21: 2.50; Expected EPS: 2.1121/4’26+7.2%2026-07-16: 2.80; Expected EPS: 2.5016/7’26−14.2%2026-10-20: 3.00; Expected EPS: 2.6420/10’26−2.3%Next reported quarter: expected earnings per share of 2.95.→21/01

Expected EPSAbove estimateBelow estimateAs expected$

Percentages below show the share’s report-day move; labels are report dates.

Next reported quarter: expected earnings per share of $2.95 (January 21). For the current fiscal year, expected earnings per share changed from $10.79 three months ago to $11.25 now. 2026 estimate: $11.25. 2027 estimate: $12.47.

Has the share price followed the business?

Price and earnings moved in the same direction: 3 out of 3 years. Across US companies, that happens in about 65% of years. In 2025, the price changed +9% and earnings per share +23%.

Revenue, profit and market cap

Revenue, profit and market cap ($B)0741472212022: 6.222022: 1.3220222023: 7.122023: 1.8020232024: 8.352024: 2.3220242025: 10.062025: 2.862025Now2026: 11.9220262027: 13.3520272022: 92.87932023: 118.851192024: 186.131862025: 201.11201Now: 159.96160

RevenueProfitMarket capHatched bars: analysts’ estimates.$B

Market cap is 15.9 times 2025 revenue, against 14.9 in 2022. Profit in 2025: $2.9B.

Assets, liabilities and market cap

Assets, liabilities and market cap ($B)0741472212022: 12.972022: 1.8620222023: 15.442023: 2.0420232024: 18.742024: 2.2120242025: 20.462025: 2.522025Now2022: 92.87932023: 118.851192024: 186.131862025: 201.11201Now: 159.96160

AssetsLiabilitiesMarket cap$B

Assets minus liabilities leave $17.9B for shareholders. Market cap is 8.9 times that equity.

Price and earnings moved in the same direction: 3 out of 3 years.Market cap (Now): $160.0BRevenue 2025: $10.1B

What the key figures say about Intuitive Surgical

The figures connect what Intuitive Surgical earns with what investors pay.

The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.

Earnings per share$8.27
NowEarnings per share2022: 3.65222023: 5.03232024: 6.42242025: 7.87252026: 11.25262027: 12.47272022: 265.352023: 337.362024: 521.962025: 566.36

Profit divided by the number of shares. Each share represents this much of the earnings.

2022–2025: $3.65–$7.87. Peers: EssilorLuxottica 5.35 EUR, Coloplast 13.64 DKK, AddLife 5.27 SEK. 2026 estimate: $11.25 ($11.14–$11.35). 2027 estimate: $12.47 ($12.03–$12.95).

Revenue$11.6B
NowRevenue2022: 6,222,200,000.00222023: 7,124,100,000.00232024: 8,352,100,000.00242025: 10,064,700,000.00252026: 11,924,179,230.00262027: 13,354,699,030.00272022: 265.352023: 337.362024: 521.962025: 566.36

What the company sold during the year.

2022–2025: $6.2B–$10.1B. Peers: EssilorLuxottica 29.3 bn EUR, Coloplast 28.9 bn DKK, AddLife 10.7 bn SEK. 2026 estimate: $11.9B ($11.5B–$12.1B). 2027 estimate: $13.4B ($12.9B–$13.8B).

Operating margin32.3%
NowOperating margin2022: 25.35222023: 24.80232024: 28.12242025: 29.27252022: 265.352023: 337.362024: 521.962025: 566.36

The percentage of revenue left after the costs of running the business.

2022–2025: 24.8%–29.3%. Peers: EssilorLuxottica 11.9%, Coloplast 25.7%, AddLife 10.1%.

Return on equity17.9%
NowReturn on equity2022: 11.98222023: 13.51232024: 14.13242025: 16.02252022: 265.352023: 337.362024: 521.962025: 566.36

Profit as a percentage of shareholders’ money in the company.

2022–2025: 12.0%–16.0%. Peers: EssilorLuxottica 6.7%, Coloplast 20.2%, AddLife 11.5%.

P/E54.8
NowP/E2022: 72.70222023: 67.07232024: 81.30242025: 71.96252026: 40.24262027: 36.3127

The price investors pay for each unit of annual earnings per share. Not shown for a loss.

2022–2025: 67.1–81.3. Peers: EssilorLuxottica 36.2, Coloplast 37.3, AddLife 34.9. 2026 estimate: 40.2. 2027 estimate: 36.3.

Market cap per unit of revenue (P/S)13.82
NowMarket cap per unit of revenue (P/S)2022: 14.93222023: 16.68232024: 22.29242025: 19.98252026: 13.42262027: 11.9827

What investors pay for each unit the company sells.

2022–2025: 14.93–22.29. Peers: EssilorLuxottica 3.03, Coloplast 3.96, AddLife 2.10. 2026 estimate: 13.42. 2027 estimate: 11.98.

More key figures
Market cap / equity (P/B)9.82
NowMarket cap / equity (P/B)2022: 8.41222023: 8.93232024: 11.33242025: 11.2825

Market cap divided by shareholders’ equity, what remains after liabilities.

2022–2025: 8.41–11.33. Peers: EssilorLuxottica 2.27, Coloplast 8.01, AddLife 3.77.

Free cash flow per share$10.18
NowFree cash flow per share2022: 2.74222023: 2.13232024: 3.66242025: 7.01252022: 265.352023: 337.362024: 521.962025: 566.36

Cash left after investments, divided by the number of shares.

2022–2025: $2.13–$7.01. Peers: EssilorLuxottica 8.22 EUR, Coloplast 28.56 DKK, AddLife 11.43 SEK.

Equity ratio87.1%
2025Equity ratio2022: 85.11222023: 86.18232024: 87.68242025: 87.1225

The percentage of assets financed by shareholders’ equity.

2022–2025: 85.1%–87.7%.

What to watch next, and why

The earnings report shows how Intuitive Surgical's revenue and profit have changed.

  • Earnings report

    The earnings report shows how Intuitive Surgical's revenue and profit have changed.

    Add to calendar

Earnings report

Next report: · Add to calendar · Google Calendar

Report day3.2%

Normal day1.3%

On its last 15 report days Intuitive Surgical usually moved about 3.2%. On a normal day it moves 1.3%.

−2.26% −14.15% +7.16% −0.35%

$10,000 in Intuitive Surgical bought on November 7, 2016 is worth $60,100 today, with dividends reinvested.

The same amount in S&P 500 with dividends would have become $40,400.

What would $10,000 in Intuitive Surgical be worth today? →

What would $10,000 in Intuitive Surgical be worth today?

$60,100

with dividends reinvested, bought on November 7, 2016. The same amount in S&P 500 with dividends would have become $40,400.

The five biggest days of the journey

· +17.4% · the whole market rose 9.4% the same day

· −14.3% · the whole market fell 2.8% the same day · report day

· +14.3% · the whole market rose 9.5% the same day

· −14.2% · the whole market fell 12.0% the same day

· −14.1% · the whole market fell 1.0% the same day · report day

Earlier days

  • +4.81% market −2.70% Intuitive Surgical rose clearly over the week, while the broader market fell sharply. Read →

    Intuitive Surgical rose clearly over the week, while the broader market fell sharply.

    Analysts raised their earnings estimates, which supported the shares.

    Its board also added Aaron Martin, a Humana executive, ahead of his 2027 start.

    Trading volume was around its usual level.

  • −2.82% market −4.41% Intuitive Surgical fell sharply. Read →

    Intuitive Surgical fell sharply.

    Its drop was in line with the Healthcare sector, which also fell very sharply.

    Trading volume was about twice a normal session.

    Directors and executives sold shares, often under trading plans set up months earlier, but those sales are background and do not establish a cause.

    Company news from the session included a legal settlement and a narrowed procedure outlook, which may partly explain the weakness.

  • +9.38% market +1.65% Intuitive Surgical rose, moving well apart from the market. Read →

    Intuitive Surgical rose, moving well apart from the market.

    The S&P 500 rose sharply over the same day, so the stock outperformed it.

    Over the past five trading days the stock rose sharply while the market slightly fell.

    Trading volume was well above its usual level, and the next earnings report is on Thursday 21 January 2027.

  • +0.89% market +0.30% Intuitive Surgical rose, an ordinary day for the stock. Read →

    Intuitive Surgical rose, an ordinary day for the stock.

    Its move was a little stronger than the S&P 500's, which rose slightly too.

    No company news explains it.

    Over the last five trading days the shares fell slightly, while the S&P 500 fell clearly and the healthcare sector rose sharply.

    Insider share sales, such as a controller's option-linked sale, are routine background and not a reason for the move.

  • +1.12% market −0.48% Intuitive Surgical rose slightly without a company-news explanation. Read →

    Intuitive Surgical rose slightly without a company-news explanation.

    Over the same day the S&P 500 fell slightly, so the stock moved against the market.

    The move was an ordinary one for Intuitive Surgical.

    Over the last five trading days the stock fell clearly, moving more than the market and against its healthcare sector, which rose sharply.

    Trading volume was well above its usual level, about twice a normal session, so more shares changed hands than usual.

  • −3.73% market −1.77% Intuitive Surgical fell sharply. Read →

    Intuitive Surgical fell sharply.

    The S&P 500 also fell sharply that day, so much of the drop likely tracked the broader market.

    Heavy selling in the session, with trading about twice its usual level, likely added to the decline.

    Over the last five trading days the shares fell clearly, while the S&P 500 fell slightly and the healthcare sector moved up, so the stock went against its sector.

    No company news explains the session's move.

  • −4.48% market −0.56% Intuitive Surgical fell clearly over the week, and the move was large against its usual daily swings. Read →

    Intuitive Surgical fell clearly over the week, and the move was large against its usual daily swings.

    Over the same days the S&P 500 slipped only slightly, so the stock fell much more than the broad market.

    The healthcare sector rose sharply, so the stock moved against its sector.

    Trading volume ran at about twice a normal session.

  • +1.90% market −0.52% Intuitive Surgical rose clearly, moving against a falling market. Read →

    Intuitive Surgical rose clearly, moving against a falling market.

    The move was partly a rebound after recent weakness, and some investors likely saw value after a 3.7% rally was noted.

    No single company event from the last session clearly explains the rise.

    Over the last five trading days the stock rose sharply, while the S&P 500 fell slightly.

    The next earnings report is on 21 January 2027.

  • +6.00% market −0.43% Intuitive Surgical rose sharply over the last five trading days, a big move for the stock. Read →

    Intuitive Surgical rose sharply over the last five trading days, a big move for the stock.

    The S&P 500 fell slightly over the same days, so the shares moved against the broader market and clearly outpaced the healthcare sector.

    The main driver was the quarterly report earlier in the week, where earnings beat expectations, although a $450 million charge from a legal settlement weighed on sentiment.

    Investors will next watch the earnings report due on 21 January 2027.

  • +3.67% market −1.18% Intuitive Surgical rose sharply, moving against a falling market. Read →

    Intuitive Surgical rose sharply, moving against a falling market.

    Over the same session the S&P 500 fell sharply, so the stock clearly outpaced both the broad market and its Healthcare sector, which also rose sharply.

    Over the last five trading days the stock rose clearly, while the S&P 500 fell slightly and the sector also rose clearly.

    Most likely the gain reflects investors returning to the stock after its quarter, where earnings beat expectations but margin pressure and a $450 million charge weighed on sentiment.

Learn more · Why do stocks go up and down?

All companies